{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:19:13Z","timestamp":1783786753453,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.anai.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T10:16:59Z","timestamp":1408529819000},"page":"476-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge"],"prefix":"10.1016","volume":"113","author":[{"given":"Hiroshi","family":"Fujishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2014.07.007_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2332\/allergolint.11-RAI-0335","article-title":"Japanese guideline for allergic conjunctival diseases","volume":"60","author":"Takamura","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.anai.2014.07.007_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0420.1999.tb01172.x","article-title":"Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis","volume":"228","author":"Abelson","year":"1999","journal-title":"Acta Opthalmol Scand Suppl"},{"key":"10.1016\/j.anai.2014.07.007_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","article-title":"Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.anai.2014.07.007_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1990.01070060068051","article-title":"Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.anai.2014.07.007_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11882-003-0100-z","article-title":"Conjunctival allergen challenge: models in the investigation of ocular allergy","volume":"3","author":"Abelson","year":"2003","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2014.07.007_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/jop.2011.0005","article-title":"Prolonged effectiveness of Bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis","volume":"27","author":"Williams","year":"2011","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.anai.2014.07.007_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1185\/03007995.2010.548797","article-title":"The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis","volume":"27","author":"Torkildsen","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anai.2014.07.007_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2332\/allergolint.55.157","article-title":"Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis","volume":"55","author":"Takamura","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.anai.2014.07.007_bib9","first-page":"1446","article-title":"In\u00a0vitro and in\u00a0vivo studies of the non-sedating antihistamine epinastine","volume":"38","author":"F\u00fcgner","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.anai.2014.07.007_bib10","first-page":"365","article-title":"Antiallergic effect of epinastine: the elucidation of the mechanism","volume":"39","author":"Tasaka","year":"1990","journal-title":"Pharmacometrics"},{"key":"10.1016\/j.anai.2014.07.007_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1254\/jjp.78.11","article-title":"Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects","volume":"78","author":"Matsushita","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.anai.2014.07.007_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08923979209009220","article-title":"Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II) antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects","volume":"14","author":"Kamei","year":"1992","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.anai.2014.07.007_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0149-2918(04)90004-5","article-title":"Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis","volume":"26","author":"Abelson","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.anai.2014.07.007_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1081-1206(10)63532-6","article-title":"Epidemiology of Japanese cedar pollinosis throughout Japan","volume":"91","author":"Okuda","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2014.07.007_bib15","first-page":"2001","article-title":"National epidemiological survey of nasal allergy 2008 (compared with 1998) in otolaryngologists and their family members","volume":"28","author":"Baba","year":"2008","journal-title":"Prog Med"},{"key":"10.1016\/j.anai.2014.07.007_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2332\/allergolint.11-RAI-0334","article-title":"Japanese guideline for allergic rhinitis","volume":"60","author":"Okubo","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.anai.2014.07.007_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ACI.0b013e328357a21b","article-title":"Molecular immunology of allergic conjunctivitis","volume":"12","author":"Irkec","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.07.007_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1755-3768.2011.02272.x","article-title":"Management of seasonal allergic conjunctivitis: guide to therapy","volume":"90","author":"Bielory","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.anai.2014.07.007_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0149-2918(04)90003-3","article-title":"Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis","volume":"26","author":"Whitcup","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.anai.2014.07.007_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1755-3768.2008.01265.x","article-title":"Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial","volume":"87","author":"Borazan","year":"2009","journal-title":"Acta Ophthalmol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120614004657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120614004657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:12:03Z","timestamp":1761052323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120614004657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1081120614004657"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2014.07.007","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}